Positive interim data presented from a phase II/III study of marzeptacog alfa July 19, 2018 No Comments
Pfizer begins pivotal phase III program for fidanacogene elaparvovec in hemophilia B July 17, 2018 No Comments
Renal anemia treatment: new oral HIF prolyl hydroxylase inhibitor promotes EPO production in rodents July 11, 2018 No Comments
Phase III trial of luspatercept in transfusion-dependent beta-thalassemia meets primary endpoint July 10, 2018 No Comments
Carbetocin is noninferior to oxytocin to prevent postpartum hemorrhage with better heat stability July 5, 2018 No Comments
Phase III MEDALIST study of luspatercept meets primary and key secondary endpoints June 29, 2018 No Comments
RSS